Background and Purpose: Several salivary markers have been utilized to evaluate acute or chronic psychological stress in various conditions. However, the clinical utility of these biomarkers in acute stroke patients remains uncertain. The aim of this study was to investigate changes in salivary stress markers related to acute stroke, both in conscious and unconscious patients, to assess the feasibility of using salivary stress markers in acute stroke patients. Subjects and Methods: A total of 27 patients with acute ischemic stroke (AIS) as shown on diffusion magnetic resonance imaging (MRI) (mean age, 67.7 ± 12.9 years; 19 males, 70.4%) and 11 control subjects were studied. Saliva was collected from patients with AIS within 24 hours after onset (Day-1), followed by serial collection at Day-4 and Day-7 using a polymer roll saturation method. Salivary concentrations of immunoglobulin A (IgA), cortisol, alpha-amylase, and dehydroepiandrosterone (DHEA) were measured by the enzyme-linked immunosorbent assay. The patients were divided into two groups based on their level of consciousness as evaluated by the National Institutes of Health Stroke Scale (NIHSS) on admission: the alert group (n=20) and the unconscious group (n=7). Motor activity on Day-1 was classified into three categories: in bed, sitting out of bed, and higher motor activity. A multiple linear regression model was used to determine independent factors associated with changes in salivary stress markers. Results: Salivary IgA and cortisol in patients with AIS at Day-1 were significantly higher than in controls (p=0.004 in IgA; p=0.002 in cortisol), and salivary amylase at Day-1 was significantly lower (p=0.049). Salivary IgA was significantly correlated with the NIHSS score (r=0.534, p=0.004) and with initial infarct volume as determined by diffusion MRI (r=0.606, p=0.001). There were no significant serial changes in any of the salivary stress markers. Multiple linear regression analyses demonstrated that motor activity levels in patients without consciousness disturbance was significantly associated with salivary IgA levels.
Introduction
Several salivary neuroendocrine markers have been utilized as a non-invasive diagnostic tool in a variety of biobehavioral studies. Salivary levels of secretory immunoglobulin A (IgA) and alpha-amylase (sAA) have been used to monitor acute physiological or psychological stress via sympathetic nervous system activity [1] [2] [3] . Salivary cortisol and dehydroepiandrosterone (DHEA) are utilized to evaluate the hypothalamic-pituitary-adrenal (HPA) axis response in several conditions 4) . Acute stroke patients admitted 23 on an emergency basis are usually placed in bed to rest. This restriction of activity may cause mental stress, but unconscious patients may be less susceptible to psychological stress. However, brain damage itself may affect these salivary biomarkers; the clinical utility of these biomarkers in acute stroke patients remains uncertain. The aim of this study was to investigate changes in salivary stress markers related to acute stroke, both in conscious and unconscious patients, to assess the feasibility of using salivary stress markers in acute stroke patients.
Subjects and Methods

Entry criteria
Eligible patients were 20 to 90 years of age, and had acute ischemic stroke (AIS) as shown by diffusion magnetic resonance imaging (MRI) evaluated within 24 hours of onset. Control subjects who met the following criteria were entered in the study: 20 to 90 years of age; no history of ischemic heart disease, ischemic or hemorrhagic stroke; no hormonal disorders such as thyroid or pituitary dysfunction; and cooperation with saliva collection and the study protocol. This study was conducted in a single hospital, and the study protocol was approved by the St. Marianna University Bioethics Committee (No. 2710). Written informed consent was obtained from all patients before study initiation, after the purpose and methods of the study were explained to either the patient or a legal proxy.
Clinical data collection
On admission, demographic data, including past history, co-morbidities, medical treatment before admission, and neurological deficits (National Institutes of Health Stroke Scale (NIHSS) score) 5) were recorded. The total score of NIHSS domain I (level of consciousness) was used for the analysis. Recorded comorbidities included hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease (CKD), and smoking habits. Hypertension was defined as two or more blood pressure measurements of ≥140/90 mmHg, or previous diagnosis of hypertension and use of antihypertensive agents. Diabetes was considered to be present if the patient showed fasting blood glucose levels ≥126 mg/dL and hemoglobin A1c (HbA1c) ≥ 6.5%, or if treatment for diabetes was being administered. Abnormal lipid metabolism was defined as total cholesterol ≥220 mg/dL, neutral fat levels ≥150 mg/dL, high-density lipoprotein (HDL) cholesterol <40 mg/dL, or use of oral agents. The presence of CKD was defined by decreased kidney function (characterized by a reduced estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m 2 ), kidney damage characterized by albuminuria or proteinuria for more than 3 months, and CKD diagnosed before entry into this study 6) . Based on clinical data including neuroimaging data, the stroke subtype was diagnosed on admission according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification 7) . Standardized assessment of all patients was performed on admission, at 24 hours and at 7 days after onset, and at discharge by the attending neurologist.
Categorization of restricted motor activity
Motor activity of patients was evaluated by a standardized method of observation developed by Askim et al 8)9) . At each observation, the following 12 activities were recorded: . These categories were: In bed: activities 1 to 4; Sitting out of bed: activities 5 to 6; and Higher motor activity: activities 7 to12.
Measurement of salivary biomarkers
Saliva was collected at the hospital between 2:00-5:00 p.m. from healthy volunteers and patients with AIS after bed rest for 30 minutes. Patients were not allowed to eat a major meal within 60 minutes of sample collection. We rinsed their mouths with distilled water to remove food residue and waited at least 10 minutes after rinsing to avoid sample dilution before collecting saliva. In patients with AIS, saliva was serially collected at Day-1, Day-4, and Day-7. A polymer roll (Salimetrics Oral Swab, Salimetrics Inc., State College, PA, USA) was placed on the tongue for 1-2 minutes to ensure that it was saturated. The polymer rolls were centrifuged (3000 rpm for 15 min) and the saliva samples were stored at −20°C. Salivary concentrations of IgA, alpha-amylase, DHEA, and cortisol were measured by enzymelinked immunosorbent assay (ELISA) using commercially available ELISA kits (IgA, Secretory ELISA Kit, Immundiagnostik AG, Bensheim, Germany; alpha-amylase, Alpha Amylase Saliva Enzymatic As-say, IBL International GmbH, Hamburg, Germany; DHEA, DHEA Saliva ELISA, IBL International GmbH, Hamburg, Germany; cortisol, Cortisol Saliva ELISA Kit, IBL International GmbH, Hamburg, Germany).
Measurement of infarct volume
Cranial MRI was performed on all patients using a 1.5-T scanner (Philips Electronics Japan, Tokyo, Japan) within 24 hours after onset. Brain volume measurement software (TRI/3D-VOL; Ratoc System Engineering, Tokyo, Japan) was used for the measurements of infarct volume using Digital Imaging and Communications in Medicine (DICOM) data of the diffusion-weighted imaging (DWI) transaxial images.
Statistical analyses
The characteristics of the study subjects are given as means and standard deviation, unless otherwise indicated. Unpaired Student's t tests were used to compare continuous variables, and χ 2 tests were used for nominal parameters. The Mann-Whitney test was used for data that were not normally distributed. A 2-sided p value of <0.05 was considered to be statistically significant. Repeated-measures analysis of variance (ANOVA) was used to compare changes over time in concentrations of salivary biomarkers. Noncorrelation was evaluated using Mauchly's sphericity test. If this assumption was not satisfied, then the Greenhouse-Geisser correction was used at a significance level of p<0.05. Multiple linear regression analysis was used to determine the effects of restriction of motor activity on salivary biomarkers after adjustment for the effects of potential confounders. These analyses were separately performed in conscious patients and unconscious patients. The total score of NIHSS domain I (level of consciousness) was used for dividing the patients into two groups, i.e., score ≥ 1: unconscious patients; score =0: conscious patients. All statistical analyses were performed using SPSS version 21 (IBM SPSS Statistics for Windows; IBM Corp, Armonk, NY, USA).
Results
Twenty-seven patients with AIS (mean age, 67.7 ± 12.9 years; 19 males, 70.4%) were enrolled. Their characteristics are shown in The eleven control subjects consisted of 7 males and 4 females (mean age, 49.1 ± 24.9 years) were studied to determine normal values of salivary markers. The control subjects were significantly younger than the patients with AIS (p=0.019). The normal values (median, 5%-95%) of salivary markers were as follows: IgA: 726.0 (257.0-1060.0) µg/mL, amylase: 100.4 (3.5-211.3) U/mL, cortisol: 118.7 (1.1-15.5) nmol/L, and DHEA: 329.4 (117.9-527.0) pg/mL.
Salivary stress markers in AIS within 24 hours after onset
The salivary stress markers in the patients with AIS at Day-1 and the values in the healthy volunteers are shown in Figure 1 . Salivary IgA and cortisol concentrations in the patients at Day-1 (<24 hours after onset) were significantly higher than those in the control subjects (2221.2 ± 2111 µg/mL vs 691.0 ± 364.4 µg/mL for IgA (p=0.004), and 26.6 ± 20.2 nmol/L vs 10.6 ± 5.1 nmol/L for cortisol (p=0.002), respectively). The salivary amylase concentrations in the stroke patients at Day-1 were significantly lower than those in the controls (60.2 ± 58.8 U/mL vs 109.8 ± 87.8 U/mL (p=0.049)). No significant difference was observed in salivary DHEA.
The univariate correlation coefficients between salivary markers and clinical factors are shown in Table 2. Salivary IgA level was significantly correlated with motor activity levels, NIHSS score, and infarct volume on Day-1. Salivary cortisol level was significantly correlated with motor activity levels on Day-1. The concentration of each salivary stress marker at Day-1 was plotted against severity of neurological deficits evaluated by the NIHSS score (Figure 2 ) and infarct volume (Figure 3) . Salivary levels of IgA were significantly correlated with the NIHSS score (r=0.400, p<0.05) and with infarct volume (r=0.590, p=0.001). Salivary levels of each stress marker at Day-1 by categories of restricted motor activity are shown in Figure 4 . Salivary IgA level was significantly different among these categories (p=0.025), and salivary IgA concentrations in patients under the in-bed motor activities were significantly higher than those under the higher motor activity condition (p= 0.036).
Multiple linear regression analyses
Multiple linear regression analyses were performed to model the salivary levels of IgA and cortisol with the following variables: age, motor activity levels, NIHSS score, and infarct volume in patients with or without consciousness disturbance on Day-1. A significant association between motor activity levels and salivary IgA level was observed in patients without consciousness disturbance ( Table 3) .
Serial changes in salivary stress markers in AIS
Concentrations in each salivary marker at Day-1, Day-4, and Day-7 are shown in Table 4 .
There were no significant differences among repeatedly measured salivary stress markers.
Discussion
In this study, salivary IgA and cortisol concentrations were significantly higher in the AIS patients tested within 24 hours after onset compared with those in the control subjects. Ring et al. 10) conducted an eight-minute Paced Auditory Serial Addition Test (PASAT) on 27 young, healthy subjects (mean age 25.57 ± 2.23 years, 20 females) to examine the relationship between blood pressure (BP), pulse, and salivary IgA. The study found that salivary IgA rose by approximately 100 µg/mL at seven to eight minutes after conducting the PASAT due to psychological stress. The same response was observed during IB: In bed, SOB: Sitting out of bed, HMA: Higher motor activity Salivary IgA level was significantly different among these categories (p=0.025, ANOVA) and concentrations in patients with IB were significantly higher than those in patients with HMA (p=0.036, post hoc analysis). administration of both alpha- 10) and beta-blockers 11) , implying the possibility that the rise in salivary IgA may be mediated by a noradrenaline effect not related to sympathetic nervous activity 12) . Similarly, Kudielka et al. 13) reported on the effects on salivary cortisol of psychological stress induced by the Trier Social Stress Test (TSST). In their study, in which the TSST was administered to 102 healthy subjects and blood and salivary cortisol concentrations were measured over time, significant increases in both blood and salivary cortisol concentrations were seen at 10 to 30 minutes after stress exposure 13) . It is known that salivary cortisol also increases with chronic stress 14)15) . Steptoe et al. 14) employed job strain scores to evaluate work-related stress among 105 healthy adults and discovered that subjects in the high chronic stress group exhibited significantly elevated salivary cortisol compared to subjects in the low chronic stress group. Furthermore, in a study that used the Trier Inventory of Chronic Stress (TICS) to assess chronic stress among young healthy subjects, Schulz et al. 15) found a significantly higher salivary cortisol concentration after waking up in highly stressed subjects. Although it can be surmised that the psychological stress experienced by stroke patients admitted on an emergency basis will differ individually, taking into account the impact of intravenous therapy, bed rest, balloon catheter placement, and other factors, one can also easily imagine such patients undergoing greater mental stress than suggested by psychological tests. Therefore, the elevated salivary IgA and cortisol observed among acute stroke patients in this study are believed to be a reasonable response.
Van Stegeren et al. 16) examined 80 healthy subjects (mean age 20.7 ± 3.2 years, 59 females) who were subjected to: (1) psychological stress in the form of emotional pictures from the International Affective Picture System (IAPS), and (2) physiological stress in the form of a cold pressor stress (CPS) procedure. Both types of stress led to an increase in salivary amylase. In addition, since increases in salivary amylase due to psychological stress can be suppressed by administering beta-blockers, Van Stegeren et al. 17) posited that salivary amylase is a sensitive indicator of sympathetic drive under stress. Nater et al. 18) investigated salivary cortisol and amylase following psychological stress induced by the TSST and found that both salivary cortisol and amylase increased immediately after stress induction. In contrast, in the present study the salivary amylase of AIS patients tested within 24 hours after onset was lower compared to that of the control subjects, and was not shown to be related to infarct volume or severity. It is still unclear why the present results differed from those of past studies. Nonetheless, we believe that although salivary amylase may be an effective marker for stress responses in healthy subjects, it may be of lesser value for assessing stress in acute stroke patients.
In the present study, no significant differences were found in salivary DHEA between AIS patients tested within 24 hours after onset and controls. Duš-ková et al. 19) reported that salivary DHEA rose in a similar manner to salivary cortisol in an experiment in which 15 healthy adults were subjected to the Synacthen (ACTH) test, indicating that ACTH regulates salivary DHEA. Izawa et al. 20) reported that psychological stress arising from two weeks of free time led to an increase in salivary DHEA. However, the present study did not detect such an effect. DHEA is known to interconvert with DHEA-sulfate (DHEA-S) through a sulfurization reaction in the bloodstream, suggesting that the length of time for obtaining salivary samples may have contributed to the absence of increase in the present study.
Only a few studies have explored the significance of salivary stress markers in acute cardiovascular disease. In a study on 473 adults brought to the hospital within four hours of developing chest pain, Shen et al. 21) compared salivary amylase levels between patients with and without acute myocardial infarction (AMI). It was consequently discovered that salivary amylase was significantly higher in the AMI group compared to that in the non-AMI group. Moreover, salivary amylase reflected not only stress from chest pain, but also the effects of AMI itself on the autonomic nervous system. As such, the findings indicate that salivary amylase can be useful as a novel diagnostic biomarker for AMI 21) . Ahmed et al. 22) conducted a study on 58 adult ischemic stroke patients within 24 hours of onset, monitoring BP and salivary cortisol for 24 hours. A positive correlation was observed between salivary cortisol and 24-hour mean systolic BP, as well as nighttime BP, indicating that stress and elevated BP are associated 22) . The present study showed increased salivary cortisol in ischemic stroke patients, as was seen in the Ahmed study, but did not indicate any correlation with severity or infarct volume. Psychological stress is primarily seen in lucid patients. The present study found high variability in salivary stress marker levels, particularly among ischemic stroke patients without impaired consciousness, indicating that these markers may be useful to evaluate the psychological stress in conscious AIS patients.
It is of great importance that our study demonstrated that restricted motor activity levels were significantly associated with salivary IgA levels in patients without consciousness disturbance. Acute stroke patients admitted on an emergency basis, with or without severe neurological deficits, are usually placed to rest in bed in order to prevent further progression and recurrence of stroke. It is reasonable to assume that this restriction of motor activity causes mental stress. This exploratory study demonstrated the potential utility of measuring salivary IgA in acute ischemic stroke patients. Further studies are warranted to explore the relationship between salivary IgA and psychological stress in acute stroke patients without consciousness disturbance.
The limitations of the present study included the following issues. First, the number of cases examined was small. In particular, the unconscious patients numbered only 7 because of the difficulty in obtaining cooperation with saliva collection in such patients. Also it is reasonable to assume that conscious but aphasic patients might suffer from severe psychological stress in the early stage of stroke. Therefore, such severely aphasic patients were not entered in this study. Second, normal values of salivary markers were obtained from younger control subjects. Among the studied salivary markers, DHEA level is known to be lower in elderly people 23)24) . Intelligence or educational background might also impact psychological stress after stroke. However, such factors were not considered confounders in this study. Third, it is well known that stroke itself affects the sympathetic nervous system 25) , the HPA axis, and the vagus nerve [26] [27] [28] ; and induces suppression of innate and adaptive peripheral immune responses 27)29) 30) . This immune suppression is referred to as stroke-induced immunodeficiency syndrome (SIDS). Experimental and clinical studies have demonstrated that SIDS occurs within hours after stroke onset and can last for up to several weeks [31] [32] [33] . The infarct volume determines the extent of immunodepression 34) . Thus, salivary stress markers in acute stroke patients may not necessarily represent only psychological stress, but may also represent SIDS. The present results demonstrated that salivary IgA is significantly increased in AIS patients, and that there is a positive correlation between this stress marker and both severity and infarct volume, especially in unconscious patients, who are less susceptible to psychological stress. Our study may suggest the potential utility of salivary IgA as a biomarker to assess SIDS.
